Recent Quarter Total Invested
$2.20 B
Recent Quarter Institutional Ownership Percentage
77.29%
Total Invested of Last Quarter
$1.90 B
Ownership Percentage of Last Quarter
87.33%
Iovance Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 26.62 M | $249.94 M | 2.64% | 8.78% |
| MHR FUND MANAGEMENT LLC | 11/14/2024 | 24.00 M | $225.33 M | 0.00% | 7.91% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 21.48 M | $201.73 M | 100.00% | 7.08% |
| STATE STREET CORP | 11/14/2024 | 13.20 M | $123.97 M | 4.57% | 4.35% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 8.53 M | $80.08 M | 12.99% | 2.81% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2024 | 8.14 M | $76.48 M | 198.07% | 2.69% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 5.86 M | $55.04 M | 185.85% | 1.93% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 5.65 M | $53.05 M | -2.38% | 1.86% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 11/12/2024 | 4.80 M | $45.11 M | -6.02% | 1.58% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 11/13/2024 | 4.53 M | $42.56 M | 9.68% | 1.49% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 4.47 M | $42.00 M | -1.50% | 1.47% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 4.39 M | $41.22 M | 67.44% | 1.45% |
| AVORO CAPITAL ADVISORS LLC | 11/14/2024 | 4.24 M | $39.81 M | -63.76% | 1.40% |
| PRINCIPAL FINANCIAL GROUP INC | 10/31/2024 | 4.03 M | $37.87 M | 59.02% | 1.33% |
| MACQUARIE GROUP LTD | 11/14/2024 | 3.19 M | $29.95 M | 100.00% | 1.05% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 3.10 M | $29.14 M | -10.90% | 1.02% |
| PALO ALTO INVESTORS LP | 11/14/2024 | 3.04 M | $28.56 M | 43.72% | 1.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 2.45 M | $23.01 M | 13.09% | 0.81% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 2.41 M | $22.60 M | 1.69% | 0.79% |
| MORGAN STANLEY | 11/14/2024 | 2.15 M | $20.18 M | -23.89% | 0.71% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 2.07 M | $19.44 M | -8.65% | 0.68% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.91 M | $17.96 M | -3.62% | 0.63% |
| JPMORGAN CHASE & CO | 11/08/2024 | 1.89 M | $17.77 M | -44.94% | 0.62% |
| RICE HALL JAMES & ASSOCIATES, LLC | 10/28/2024 | 1.68 M | $15.77 M | 2.64% | 0.55% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 1.41 M | $13.28 M | 42.58% | 0.47% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.40 M | $13.15 M | -6.67% | 0.46% |
| EAGLE ASSET MANAGEMENT INC | 11/12/2024 | 1.36 M | $14.36 M | -29.98% | 0.45% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 1.32 M | $12.41 M | -0.45% | 0.44% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 1.28 M | $12.05 M | 75.36% | 0.42% |
| C WORLDWIDE GROUP HOLDING A/S | 11/05/2024 | 1.26 M | $11.83 M | 0.00% | 0.42% |
| NEW YORK STATE COMMON RETIREMENT FUND | 10/28/2024 | 1.22 M | $11.46 M | 0.94% | 0.40% |
| SIREN, L.L.C. | 11/13/2024 | 1.11 M | $10.39 B | 100.00% | 0.36% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 11/13/2024 | 1.05 M | $9.88 M | 14.40% | 0.35% |
| CITADEL ADVISORS LLC | 11/14/2024 | 1.02 M | $9.61 M | 320.88% | 0.34% |
| ORION INVESTMENT CO | 11/13/2024 | 906,285 | $8.51 M | 14.04% | 0.30% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 902,268 | $8.66 M | -1.94% | 0.30% |
| CUTTER CAPITAL MANAGEMENT, LP | 11/14/2024 | 876,009 | $8.23 M | 100.00% | 0.29% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 841,969 | $7.91 M | -18.63% | 0.28% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 807,100 | $7.58 M | -18.41% | 0.27% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 794,500 | $7.46 M | 28.50% | 0.26% |
| BOXER CAPITAL, LLC | 11/14/2024 | 750,000 | $7.04 M | 0.00% | 0.25% |
| QVT FINANCIAL LP | 11/14/2024 | 678,564 | $6.37 M | 0.00% | 0.22% |
| APIS CAPITAL ADVISORS, LLC | 11/14/2024 | 675,000 | $6.34 M | 100.00% | 0.22% |
| CITADEL ADVISORS LLC | 11/14/2024 | 656,700 | $6.17 M | 54.96% | 0.22% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 652,966 | $6.13 M | -9.83% | 0.22% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 631,130 | $5.93 M | 91.23% | 0.21% |
| UBS GROUP AG | 11/14/2024 | 622,129 | $5.84 M | -21.76% | 0.21% |
| BARCLAYS PLC | 11/19/2024 | 604,584 | $5.68 M | 118.81% | 0.20% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 575,844 | $5.41 M | 16.01% | 0.19% |
| WOODLINE PARTNERS LP | 11/14/2024 | 562,435 | $5.28 M | 100.00% | 0.19% |
Iovance Biotherapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of IOVA shares?
During the previous two years, 366 institutional investors and hedge funds held shares of Iovance Biotherapeutics, Inc.. The most heavily invested institutionals were:
PERCEPTIVE ADVISORS LLC: 26.62 M
MHR FUND MANAGEMENT LLC: 24 M
BlackRock Funding, Inc. /DE: 21.48 M
STATE STREET CORP: 13.2 M
Soleus Capital Management, L.P.: 8.53 M
Hood River Capital Management LLC: 8.14 M
-
What percentage of Iovance Biotherapeutics, Inc. stock is owned by institutional investors?
77.29% of Iovance Biotherapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at IOVA ?
Institutional investors have bought a total of 233.64 M shares in the last 24 months. This purchase volume represents approximately $1.93 B in transactions.